Vnitr Lek 2015, 61(12):1010-1014

Regional registry of pulmonary embolism

Mária Záňová*, Zdeněk Monhart
Interní oddělení Nemocnice Znojmo, prim. MUDr. Zdeněk Monhart, Ph.D.

Introduction:
Pulmonary embolism (PE) together with coronary heart disease and arterial hypertension are most common diseases of cardiovascular system. Due to its high mortality rate it is worth of attention.

Aim:
to describe characteristics of patients with PE, provide data about treatment and inpatient mortality rate. Also to identify an occurence of right-sided heart thrombi in patients with PE and efficiency/safety of thrombolytic therapy in this subpopulation. To evaluate effectiveness/importance of basic oncology screening in patients with PE (meaning efficiency of provided examinations to uncover hidden malignancy).

Methods:
Our registry is based on observation of consecutive patients with PE hospitalized in our hospital (catchment area of Znojmo region, 130 000 inhabitants) since July 2011 until April 2014. We collected data about 188 patients diagnosed with acute or subacute PE by perfusion lung scan, CT angiography or typical symptoms with echocardiography findings.

Results:
In the cohort there were 71 men (37.8 %) and 117 women (62.2 %), average age 66 years (16-94), 72.9 % of patients were older than 60 years of age. History of thromboembolic disease was present in 37 patients (19.7 %), malignancy in 36 of them (19.1 %), signs of deep vein thrombosis in 36 patients (19.1 %), hereditary thrombophilia in 11 (5.9 %), recent injury with immobilisation in 10 (5.3 %), recent surgery in 14 patients (7.4 %) and atrial fibrillation in 22 patients (11.7 %). Right heart thrombi werefound in 3 patients (1.6 %) out of 176 who were examined. Hospital mortality rate reached 5.6 %, 3 months mortality rate was 9.4 % (data collected from 85.1 % of all patients) and 1 year mortality rate was 19.1 % (data from 61.2 % of all patients). An occult cancer was diagnosed during hospital stay only in 3 patients (1.6 %), another 6 malignancies manifested themselves after longer period of time. Median length of hospital stay was 7 days. Thrombolysis was used in 14 patients (7.4 %). Bleeding complications of anticoagulant or thrombolytic therapy occured in 4 patients (2.1 %) during hospital care - epistaxis, severe haematoma of extremities with necessity of surgical treatment and haematemesis in 2 patients. Cerebral hemorrhage was not present in our cohort of patients.

Conclusion:
PE isn't rare condition, we can encounter it in various medical fields, but due to its diversity of symptoms and unclear prognosis, it continues to be serious clinical problem. Hospital mortality rate is higher in patients with PE than in those with acute coronary syndrome, which is in accordance with published data. Detection of right-sided heart thrombi is about half of that described in literature. Prevalence of dyspnoe and chest pain are consistent with reported data, but occurence of syncope and hemoptysis in our registry is far less common. Screening of occult cancer could be more effective. The therapy seems to be safe, a life threatening bleeding was not present even when thrombolysis was used.

Keywords: echocardiography; mortality; pulmonary embolism; registry

Received: March 11, 2015; Accepted: May 31, 2015; Published: December 1, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Záňová M, Monhart Z. Regional registry of pulmonary embolism. Vnitr Lek. 2015;61(12):1010-1014.
Download citation

References

  1. Lobo JL, Zorrilla V, Aizpuru F et al. Clinical syndromes and clinical outcome in patients with pulmonary embolism: findings from the RIETE registry. Chest 2006; 130(6): 1817-1822. Go to original source... Go to PubMed...
  2. Kasper W, Konstantinides S, Geibel A et al. Management Strategies and Determinants of Outcome in Acute Major Pulmonary Embolism: Results of a Multicenter Registry. J Am Coll Cardiol 1997; 30(5): 1165-1171. Go to original source... Go to PubMed...
  3. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353(9162): 1386-1389. Go to original source... Go to PubMed...
  4. Kincl V, Drozdová A, Panovský R et al. Zobrazovací metody v diagnostice a stratifikaci rizika akutní plicní embolie. Interv Akut Kardiol 2014; 13(1): 17-22.
  5. Konstantinides S, Torbicki A, Agnelli G et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35(43): 3033-3080. Go to original source... Go to PubMed...
  6. Righini M, Van Es J, Den Exter P et al. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Pulmonary Embolism The ADJUST-PE Study. JAMA 2014; 311(11): 1117-1124. Go to original source... Go to PubMed...
  7. Widimský J, Malý J, Eliáš P et al. Doporučení diagnostiky, léčby a prevence plicní embolie. Verze 2007. Doporučení České kardiologické společnosti. Vnitř Lék 2008; 54(Suppl 1): S25-S72.
  8. Carrier M, Le Gal G, Wells PS et al. Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008; 149(5): 323. Go to original source... Go to PubMed...
  9. Dytrych V, Bělohlávek J, Král A et al. Zásadní role echokardiografie u akutní plicní embolie. Interv Akut Kardiol 2011; 10(Suppl A): 17-19.
  10. Torbicki A, Perrier A, Konstantinides S et al. Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2008; 29(18): 2276-2315. Go to original source... Go to PubMed...
  11. Vieillard-Baron A, Jardin F. Acute Right Ventricular Dysfunction: Focus on Acute Cor Pulmonale. In: Hill NS, Farber HW et al. Pulmonary hypertension (Contemporary Cardiology). Humana Press 2008: 363-382. ISBN 978-1617377020. Go to original source... Go to PubMed...
  12. Widimský J. Diagnostika a léčba akutní plicní embolie v roce 2010. Vnitř Lék 2011; 57(1): 5-21. Go to PubMed...
  13. Stein PD, Matta F. Thrombolytic therapy in unstable patients with pulmonary embolism: saves lives but underused. Am J Med 2012; 12(5): 465-470. Go to original source... Go to PubMed...
  14. Widimský J. Diagnosis and treatment of acute pulmonary embolism. Cor et Vasa 2013; 55: e497-e509. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2013.10.001>. Go to original source...
  15. Bělohlávek J, Dytrych V, Král A et al. Závažná plicní embolie. Interv Akut Kardiol 2011; 10(Suppl A): 6-13.
  16. Král A, Bělohlávek J, Dytrych V et al. Současná léčba pacientů s akutní a subakutní plicní embolii s ohledem na nově publikovaná doporučení diagnostiky a léčby tohoto onemocnění. Cor Vasa 2009; 51(11-12): 767-772. Go to original source...
  17. Hospitalizovaní v nemocnicích ČR. 2012. Ústav zdravotnických informací a statistiky ČR (ÚZIS ČR): Praha 2012. ISBN 978-80-7472-090-1. Dostupné z WWW: <http://www.uzis.cz/publikace/hospitalizovani-nemocnicich-cr-2012>.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.